Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms, Unknown Primary 1Neoplasms 1Genetic Predisposition to Disease 1Disease 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Sequence Analysis, RNA × 1 year × Clear all
NCT07366008 2026-01-26

NorCUP

Haukeland University Hospital

Phase NA Not yet recruiting
350 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT04620278 2026-01-06

Genetic Investigation of Cancer Predisposition

The University of Texas Health Science Center at San Antonio

Not yet recruiting
100 enrolled

Disease, Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡